AIM ImmunoTech: Ownership Filing Amendment

TL;DR

AIM ImmunoTech 13D/A filed by Sweeney, Kellner, Springate group - ownership update.

AI Summary

On December 17, 2024, Paul W. Sweeney, Ted D. Kellner, and Wayne Springate filed an amendment (No. 9) to their Schedule 13D for AIM ImmunoTech Inc. The filing indicates a change in beneficial ownership of the company's common stock. The group, which includes Todd Deutsch, is represented by Baker & Hostetler LLP.

Why It Matters

This filing signals a potential shift in control or strategy for AIM ImmunoTech Inc. as significant shareholders update their beneficial ownership information.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate actions or changes in control, which can introduce volatility.

Key Players & Entities

• Paul W. Sweeney (person) — Filing group member
• Ted D. Kellner (person) — Filing group member
• Wayne Springate (person) — Filing group member
• Todd Deutsch (person) — Filing group member
• AIM ImmunoTech Inc. (company) — Subject company
• Baker & Hostetler LLP (company) — Legal representative

FAQ

Key Financial Figures

• $0.001 — me of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti

Filing Documents

• d863168dsc13da.htm (SC 13D/A) — 73KB
• d863168dex991.htm (EX-99.1) — 13KB
• d863168dex992.htm (EX-99.2) — 4KB
• 0001193125-24-280492.txt ( ) — 91KB

is

Item 2 is supplemented as follows: This Amendment No. 9 is being filed jointly by Mr. Deutsch, Mr. Kellner, Mr. Sweeney and Mr. Springate. Mr. Springates business address is P.O. Box 111, Lake Harmony, PA 18624. He is the Managing Member of WLJ Holdings LLC, a company specializing in building healthcare companies in certain niches to meet unmet needs. Mr. Springate is a U.S. citizen. During the last five years, none of the Reporting Persons has been convicted in a criminal proceeding. During the last five years, none of the Reporting Persons was party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or Item3. Source and Amount of Funds or Other Consideration

is supplemented as follows

Item 3 is supplemented as follows: Mr. Springate acquired the shares of Common Stock he beneficially owns pursuant to awards made under equity compensation plans of the Company. Item5. Interest in Securities of the Issuer Mr. Springate is the beneficial owner of 4,660 shares of Common Stock, or 0.007% of the Companys outstanding shares. He has sole voting and dispositive power over these shares. The Group consisting of the Reporting Persons owns an aggregate of 3,215,660 shares of Common Stock, or 5.04% of the Companys outstanding shares. The foregoing is based on 63,779,325 shares of Common Stock outstanding as reported in a Prospectus filed by the Company pursuant to Rule 424(b)(5) on December 4, 2024 with the Securities and Exchange Commission (File No. 333-283269). Item6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

is hereby supplemented as follows

Item 6 is hereby supplemented as follows: On December 14, 2024, each of William A. Carter and Mr. Springate joined, as Cooperating Parties, the agreement, dated September 3, 2024 and amended September 11, 2024 , among the other Reporting Persons and Mr. Chioini for the limited purposes set forth therein. The Coordinating Parties will not take Coordinated Actions (as defined in the agreement) without the approval of Mr. Kellner. Mr. Kellner and the Other Nominees may take Coordinated Actions without the approval or review of the Cooperating Parties, provided that no communications or public statements by Mr. Kellner or the Other Nominees will be attributed to, incorporate substantive information provided by or otherwise reference the Cooperating Parties in a substantive manner without their prior approval of those (and just those) specific portions of such communications or public statements, unless substantially consistent with prior communications, public statements or other disclosures previously approved by the Cooperating Parties. The agreement terminated by its terms upon the completion of the Companys annual meeting of stockholders held on December 17, 2024. The Reporting Persons expect to determine whether to continue to coordinate their activities with respect to the Company once the final results of the annual meeting are available. The foregoing summary is qualified by reference in its entirety by the terms and conditions of the joinder to the agreement, a copy of which is attached hereto as Exhibit 1. Item7. Material to be Filed as Exhibits

is hereby supplemented by adding the following exhibits

Item 7 is hereby supplemented by adding the following exhibits: Exhibit No. Name 1. Joinder to Agreement, dated December 14, 2024 2. Joint Filing Agreement

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned hereby certifies that the information set forth in this statement is true, complete and correct. Date: December 17, 2024 TODD DEUTSCH By: /s/ Todd Deutsch TED D. KELLNER By: /s/ Ted D. Kellner PAUL W. SWEENEY By: /s/ Paul W. Sweeney WAYNE SPRINGATE By: /s/ Wayne Springate

View Full Filing

View this SC 13D/A filing on SEC EDGAR